Home

Maurice Zauderer

CIK 1747753 · President and CEO · last filed 2024-05-14

Maurice Zauderer is a President and CEO who has filed 15 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing, for VCNX, was dated May 14, 2024. Across all open-market trades the lifetime net is +$4.3M, making them a net buyer over the disclosed history. 28 SEC filings were submitted jointly with VACCINEX, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

15

Lifetime Open-Market Net

$4.27M

Filer Profile

Reported Address
1895 MOUNT HOPE AVENUE
ROCHESTER, NY 14620
Related Filers
VACCINEX, INC. — 28 joint filings, latest 2024-11-18
Vaccinex (Rochester), L.L.C. — 8 joint filings, latest 2024-11-18
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VACCINEX, INC. (VCNX) Delisted President and CEO 2,596 $1.00 $2.6K $4.27M 15 2024-05-14

Recent Filings

15 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-05-14 VACCINEX, INC. (VCNX) Delisted Grant (A) — $0 EDGAR
2024-03-22 VACCINEX, INC. (VCNX) Delisted Grant (A) — $0 EDGAR
2024-02-09 VACCINEX, INC. (VCNX) Delisted Grant (A) +827,586 $600.0K EDGAR
2023-10-05 VACCINEX, INC. (VCNX) Delisted Buy (P) +1,020,000 $1.02M EDGAR
2023-09-25 VACCINEX, INC. (VCNX) Delisted Grant (A) +2,051,282 $320.0K EDGAR
2023-04-03 VACCINEX, INC. (VCNX) Delisted Grant (A) +731,707 $300.0K EDGAR
2022-12-07 VACCINEX, INC. (VCNX) Delisted Will (W) +3,988 $0 EDGAR
2022-11-28 VACCINEX, INC. (VCNX) Delisted Grant (A) +1,511,430 $800.0K EDGAR
2022-04-04 VACCINEX, INC. (VCNX) Delisted Grant (A) — $0 EDGAR
2022-01-31 VACCINEX, INC. (VCNX) Delisted Buy (P) +1,801,801 $2.00M EDGAR
Showing 1–10 of 15
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.